Mimedx (MDXG) Total Debt (2011 - 2026)
Mimedx recorded quarterly Total Debt of $17.6 million in Q1 2026, down 2.08% quarter-over-quarter from $18.0 million in Q4 2025, and down 5.7% year-over-year from $18.7 million in Q1 2025.
Mimedx's Total Debt history runs 12 years deep, the most recent figure standing at $17.6 million for Q1 2026.
- In Q1 2026, Total Debt fell 5.7% year-over-year to $17.6 million; the TTM figure through Mar 2026 stood at $17.6 million (down 5.7% YoY), while the FY2025 annual figure was $18.0 million, down 4.58% from the prior year.
- Total Debt came in at $17.6 million for Q1 2026 at Mimedx, down from $18.0 million in the prior quarter.
- In the past five years, Total Debt ranged from a high of $49.1 million in Q4 2023 to a low of $17.6 million in Q1 2026.
- A 5-year average of $32.8 million and a median of $20.4 million in 2024 frame the typical range for Total Debt.
- Across the five-year window, Total Debt gained 1.04% in 2023 and tumbled 61.65% in 2024, its largest moves.
- Mimedx's Total Debt stood at $48.6 million in 2022, then gained by 1.04% to $49.1 million in 2023, then plunged by 61.65% to $18.8 million in 2024, then slipped by 4.58% to $18.0 million in 2025, then retreated by 2.08% to $17.6 million in 2026.
- According to Business Quant data, Total Debt over the past three periods registered $17.6 million, $18.0 million, and $18.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 319.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 110.96 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 1.99 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Mimedx | 530.69 Mn | 370.92 Mn | 41.62 Mn | 17.59 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 17.59 Mn |
| Dec 31, 2025 | 17.97 Mn |
| Sep 30, 2025 | 18.21 Mn |
| Jun 30, 2025 | 18.46 Mn |
| Mar 31, 2025 | 18.66 Mn |
| Dec 31, 2024 | 18.83 Mn |
| Sep 30, 2024 | 19.02 Mn |
| Jun 30, 2024 | 20.45 Mn |
| Mar 31, 2024 | 19.45 Mn |
| Dec 31, 2023 | 49.10 Mn |
| Sep 30, 2023 | 48.97 Mn |
| Jun 30, 2023 | 48.84 Mn |
| Mar 31, 2023 | 48.71 Mn |
| Dec 31, 2022 | 48.59 Mn |
| Sep 30, 2022 | 48.48 Mn |
| Jun 30, 2022 | 48.36 Mn |
| Mar 31, 2022 | 48.24 Mn |
| Dec 31, 2021 | 48.13 Mn |
| Sep 30, 2021 | 48.02 Mn |
| Jun 30, 2021 | 47.91 Mn |
| Mar 31, 2021 | 47.80 Mn |
| Dec 31, 2020 | 47.70 Mn |
| Sep 30, 2020 | 47.63 Mn |
| Jun 30, 2020 | 65.22 Mn |
| Mar 31, 2020 | 65.39 Mn |
| Dec 31, 2019 | 65.66 Mn |
| Sep 30, 2019 | 65.92 Mn |
| Jun 30, 2019 | 66.82 Mn |
| Jun 30, 2017 | 17.57 Mn |
| Mar 31, 2017 | 8.74 Mn |
| Dec 31, 2016 | 8.26 Mn |
| Sep 30, 2016 | 9.64 Mn |
| Jun 30, 2016 | 9.64 Mn |
| Sep 30, 2012 | 1.17 Mn |
| Jun 30, 2012 | 2.04 Mn |
| Mar 31, 2012 | 1.78 Mn |
| Dec 31, 2011 | 2.42 Mn |
| Sep 30, 2011 | 1.27 Mn |
| Jun 30, 2011 | 7,704.00 |